• 2358 Citations
  • 19 Scopus h-Index
20022019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Vinaya Simha is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Congenital Generalized Lipodystrophy Medicine & Life Sciences
Lipodystrophy Medicine & Life Sciences
Familial Partial Lipodystrophy Medicine & Life Sciences
Leptin Medicine & Life Sciences
Lamin Type A Medicine & Life Sciences
Body Fat Distribution Medicine & Life Sciences
Dyslipidemias Medicine & Life Sciences
Insulin Resistance Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Glucose Control in the Perioperative Period - Reply

Simha, V. & Shah, P., Jul 2 2019, In : JAMA - Journal of the American Medical Association. 322, 1, p. 82-83 2 p.

Research output: Contribution to journalLetter

Perioperative Period
Glucose
6 Citations (Scopus)

Perioperative Glucose Control in Patients with Diabetes Undergoing Elective Surgery

Simha, V. & Shah, P., Jan 29 2019, In : JAMA - Journal of the American Medical Association. 321, 4, p. 399-400 2 p.

Research output: Contribution to journalShort survey

Glucose
102 Citations (Scopus)

Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: The ODYSSEY ESCAPE trial

Moriarty, P. M., Parhofer, K. G., Babirak, S. P., Cornier, M. A., Duell, P. B., Hohenstein, B., Leebmann, J., Ramlow, W., Schettler, V., Simha, V., Steinhagen-Thiessen, E., Thompson, P. D., Vogt, A., Von Stritzky, B., Du, Y. & Manvelian, G., Jan 1 2016, In : European heart journal. 37, 48, p. 3588-3595 8 p.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Blood Component Removal
Lipoproteins
Placebos
LDL Cholesterol
11 Citations (Scopus)

Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial

Moriarty, P. M., Parhofer, K. G., Babirak, S. P., Degoma, E., Duell, P. B., Hohenstein, B., Ramlow, W., Simha, V., Steinhagen-Thiessen, E., Thompson, P. D., Vogt, A., Von Stritzky, B., Du, Y. & Manvelian, G., May 1 2016, In : Journal of Clinical Lipidology. 10, 3, p. 627-634 8 p.

Research output: Contribution to journalArticle

Open Access
Hyperlipoproteinemia Type II
Blood Component Removal
Lipoproteins
LDL Cholesterol
Placebos
3 Citations (Scopus)

HDL cholesterol story is dead: Long live HDL!

Simha, V. & Kudva, Y. C., Oct 1 2016, In : Diabetes. 65, 10, p. 2826-2828 3 p.

Research output: Contribution to journalComment/debate